Exposure to treosulfan and fludarabine did not impact MSLN-CAR T cells effectors functions (degranulation and cytokine production) or mitochondrial defects, while combination of treosulfan and fludarabine decreased MSLN-CAR T cells anti-tumor killing in normoxia but not in hypoxia. This evidence concerns the gene MSLN and neoplasm.